-+ 0.00%
-+ 0.00%
-+ 0.00%

Alnylam Pharmaceuticals Price Target Cut to $205.00/Share From $290.00 by Cantor Fitzgerald

Dow Jones·11/17/2026 12:01:00

Please log in to view news